Recure Biotechnology & Cosmetics Limited
13919740
Some Concerns
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/12/2025
micro entity
Next accounts due
30/09/2027
Confirmation statement
Last: 16/09/2025
Due 30/09/2026
Industry
Officers
director · Since 16/02/2022
DIRECTOR
SLOVAK · UNITED KINGDOM · Age 57
Also on 7 other boards
Former
director · Resigned 10/10/2022
Persons with Significant Control
London Regenerative Inst Ltd
Riverside East, 2 Millsands, Sheffield, S3 8DT
Reg: 13289356 · Companies House · Private Limited Company
Notified 27/04/2022
Former PSCs
Sage Biotechnology Limited
Ceased 07/03/2022
Dr Kemal Tiryaki
Ceased 27/04/2022
Sage Biotechnology Limited
Ceased 29/11/2023
Dr Kemal Tunc Tiryaki
Ceased 21/05/2024
Change History
Active
Private Limited Company
C/O IRWIN MITCHELL LLP RIVERSIDE EAST
SHEFFIELD
CompanyRankvs 503+ SIC 21200 peers26
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2025
Net Worth
-£484k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
-£501k
Working capital
Current Assets
-£12k
Current Liabilities
£489k
Fixed Assets
£18k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | -0.02 | -£175k |
| 2024 | -3.00 | -£197k |
| 2023 | 0.30 | — |
Derived from filed accounts. Not audited figures.